Shanshui Technology: Abnormal Fluctuations in Stock Trading, Limited Impact from 6-Nitrobody Price Fluctuations

Shanshui Technology announced that the company's stock closing prices rose by a cumulative deviation of more than 30% over three consecutive trading days, constituting an abnormal fluctuation in stock trading. Upon verification, the company's recent operations are normal, and no major changes have occurred in the internal or external operating environment; it has noted market rumors on platforms such as Hudongyi regarding price fluctuations of 6-nitro compounds. The price and sales volume of this product move in a certain inverse relationship, and the impact on the company's performance is currently expected to be limited. The company, its controlling shareholder, and its actual controller have no major undisclosed matters that should be disclosed, and the actual controller and controlling shareholder did not buy or sell the company's stock during the period of abnormal fluctuation. As of September 28, 2026, the company's trailing price-to-earnings ratio was 49.01 times, higher than the industry level of 21.43 times. Investors are kindly reminded to pay attention to investment risks.